Sign in

You're signed outSign in or to get full access.

Joseph Burnett

Joseph Burnett

Chief Executive Officer and President at ClearPoint Neuro
CEO
Executive
Board

About Joseph Burnett

Joseph M. Burnett, 48, is Chief Executive Officer and President of ClearPoint Neuro (joined November 2017) and a director; he holds an MBA from Duke’s Fuqua School and a B.S.E. in Biomedical Engineering from Duke . Under his tenure, the company reported 31% year-over-year revenue growth in 2024 and reduced operational cash burn by 35% versus 2023, leading the Compensation Committee to award above-target bonuses for 2024 . Pay-versus-performance disclosures show total shareholder return rising to $137.08 for an initial $100 investment in 2024 (from $42.73 in 2023) while net losses persisted, highlighting a growth-at-scale strategy with improving stock performance despite negative net income . Burnett serves as CEO and director with the chair role separated (Chairman: R. John Fletcher); six of eight directors are independent, and the independent chair of Corporate Governance and Nominating acts as Lead Independent Director when needed to mitigate dual-role risks .

Past Roles

OrganizationRoleYearsStrategic Impact
PhilipsVP & GM, Neuro Diagnostics & Therapy2016–2017Led neuro business in a global health tech company
Philips (incl. Volcano)SVP & Business Leader, Image Guided Therapy Devices; GM, Volcano2015–2016Oversaw IGT devices portfolio and integration post-acquisition
Volcano CorporationEVP & GM, Coronary & Systems BU; prior roles2004–2015Grew coronary/systems businesses; device commercialization
Guidant CorporationR&D Engineer, Product Manager1999–2004Early-stage device engineering and product roles
Duke UniversityBiomedical Engineering Researcher1998–1999Academic research foundation in biomedical engineering

External Roles

No external public company directorships disclosed for Burnett in the proxy materials .

Fixed Compensation

Metric20232024
Base Salary ($)$517,692 $537,692
Salary Rate (as-of date)$520,000 (Feb 6, 2023) $540,000 (Feb 4, 2024)
Target Bonus %75% (as of Jan 1, 2023) 90% (as of Jan 1, 2024)
All Other Compensation ($)$12,424 $14,587

Performance Compensation

Annual Incentive

ComponentTargetActualBasis
Annual Bonus for FY2024 (paid Q1 2025)$486,000 $680,400 Committee cited 31% revenue growth and 35% cash burn reduction in 2024

Notes: Weightings and specific quantitative target thresholds for annual bonus were not disclosed; the Committee referenced above-plan performance and strategic financing initiatives (follow-on offering, ATM facility) .

Long-Term Incentives (Equity)

Grant TypeGrant DateShares/UnitsFair Value ($)Vesting Schedule
RSUMay 20, 2024212,071 $1,299,995 20% on Mar 12, 2025; 40% on Mar 12, 2026 and Mar 12, 2027
RSUMar 3, 2025132,841 $1,800,000 20% on 1st anniversary; 40% on 2nd and 3rd anniversaries
OptionNov 7, 2017350,000 (Exercisable) Strike $2.50; Exp 11/7/2027
OptionAug 15, 201974,404 (Exercisable) Strike $3.47; Exp 8/15/2029
OptionJul 9, 202052,356 (Exercisable) Strike $3.24; Exp 7/9/2030
OptionAug 20, 202129,377 (Exercisable) Strike $16.71; Exp 8/20/2031
OptionJun 10, 202228,046 (Exercisable); 18,697 (Unexercisable) Strike $11.41; Exp 6/10/2032
OptionMar 6, 20237,901 (Exercisable); 31,605 (Unexercisable) Strike $8.10; Exp 3/6/2033

None of the named executive officers exercised stock options in 2024, reducing mechanical sell pressure; vesting RSUs may create supply at future dates unless deferral/election applies .

Equity Ownership & Alignment

Ownership Metric (as of Mar 24, 2025)Value
Beneficially Owned Shares (#)848,017; 2.97% of outstanding
BreakdownIncludes 28,045 restricted shares with voting power and 557,885 options exercisable within 60 days
Shares Outstanding (basis for %)27,979,560
CEO Ownership GuidelineRequired = 500% of base salary
Base Salary (as of Feb 1, 2025)$590,000
Required Holding (Dollar)$2,950,000 (computed 500% × $590,000)
Holding Value (approx.)~$11.7 million, using $13.78 share price on 3/24/2025 × 848,017 shares (13.78 × 848,017)

Stock ownership guidelines count vested options as beneficial ownership; Burnett appears to exceed requirements materially at the record-date share price .

Employment Terms

TermKey Provision
Role & StartCEO & President; agreement entered Nov 2017; amended Mar 2023
Base Salary FloorCannot be less than $360,000; annual base may not be reduced >10% from prior year
Target Bonus40% of base (increased to 90% for 2024 per Committee decision)
Term & RenewalOriginal 3-year term; auto-renews annually each Nov 7 unless non-renewal ≥90 days prior
Non-Compete/Non-SolicitConfidentiality; assignment-of-inventions; non-compete during employment and for one year post-termination (subject to unenforceability post-employment in California); non-solicit provisions
Severance (No Cause/Good Reason/Non-renewal)Lump sum: 1× base salary + average bonus for previous two years + $18,000; equity vesting accelerates: pre–Mar 3, 2023 awards fully vest; post–Mar 3, 2023 awards scheduled to vest within 12 months vest; option post-termination exercise windows per agreement
Change-of-Control (Double Trigger)Equity fully vests upon CoC; if terminated without cause or for good reason within 2 months before or 12 months after CoC: 2× base + 2× average of two highest bonuses in prior three years + $18,000; option exercise window up to 3 years
ClawbackCompensation Recoupment Policy adopted Oct 2023; awards subject to clawback under Dodd-Frank/SOX and listing rules

Board Governance

  • Board service: Burnett has been a director since November 2017; current Board fixed at eight directors with annual elections .
  • Independence: Six of eight directors are independent under Nasdaq rules; Burnett (CEO) is not independent .
  • Leadership structure: Chairman is independent (R. John Fletcher); CEO role is separate; Lead Independent Director duties assigned to the independent Corporate Governance & Nominating chair when chair is not independent, supporting oversight and executive sessions .
  • Committee composition (Burnett not listed as a member): Audit (Chair: Lynnette C. Fallon; members: Pascal E.R. Girin, R. John Fletcher) ; Compensation (Chair: B. Kristine Johnson; members: Linda M. Liau, Timothy T. Richards) ; Corporate Governance & Nominating (Chair: Timothy T. Richards; members: R. John Fletcher, Lynnette C. Fallon) .
  • Attendance: Board held five meetings in 2024; all directors attended ≥75% of meetings; seven directors attended the 2024 Annual Meeting .

Director Compensation (context for dual-role)

  • Employee directors (including Burnett) do not receive board fees; non-employee directors receive cash retainers and annual RSU grants valued at $135,000, with optional fee payment in stock .

Say-on-Pay & Peer Benchmarking

  • Say-on-Pay: ~95% approval in 2024, indicating strong shareholder support for executive pay .
  • Peer benchmarking: Compensation Committee engaged independent consultant Haigh & Company in 2024; conducted conflict-of-interest assessment; peer market data informed salary/bonus decisions .

Risk Indicators & Red Flags

  • Legal proceedings: None disclosed for current directors/executives in last 10 years .
  • Hedging/pledging: Proxy references Insider Trading and Recoupment policies; specific hedging/pledging practices for Burnett are not separately disclosed in proxy .
  • Equity repricing/modification: No repricing disclosed; plan allows Committee flexibility under CoC with fair value treatment and potential cancellation of underwater options .
  • Option exercises: None by NEOs in 2024, suggesting limited forced selling from exercise taxes .

Detailed Vesting Calendar (Supply Considerations)

AwardNext Vest Date(s)Amount
2024 RSU (212,071 units)Mar 12, 2026 (40%); Mar 12, 2027 (40%) after 20% on Mar 12, 2025
2025 RSU (132,841 units)Mar 3, 2026 (20%); Mar 3, 2027 (40%); Mar 3, 2028 (40%)
2023 Options ($8.10)40% vests Mar 6, 2025; 40% Mar 6, 2026 (balance unexercisable as of 12/31/2024: 31,605)

Upcoming RSU vesting dates could add sellable shares; however, Burnett materially exceeds ownership guidelines, aligning incentives to hold .

Multi-Year Compensation Summary

Metric20232024
Total Compensation ($)$1,995,337 $2,532,674
Stock Awards ($)$959,996 $1,299,995
Option Awards ($)$232,225
Non-Equity Incentive ($)$273,000 $680,400

Pay vs Performance (Company-level context)

YearCompensation Actually Paid to PEO ($)TSR (Initial $100)Net Income (Loss, $000s)
2022$1,933,980 $53.30 (16,435)
2023$1,460,479 $42.73 (22,089)
2024$5,879,998 $137.08 (18,914)

Investment Implications

  • Alignment: Burnett’s ownership (~2.97%, ~$11.7m at $13.78) far exceeds the CEO guideline (500% of salary), reinforcing long-term alignment and reducing short-term sell pressure despite RSU vesting cadence .
  • Incentive design: Cash bonus outcomes explicitly tied to operational performance (31% revenue growth; 35% burn reduction) and strategic financing, though specific weightings/targets are undisclosed—suggesting Committee discretion but directionally pay-for-performance .
  • Retention and CoC economics: Double-trigger CoC provides 2× base and 2× average of two highest bonuses plus full equity vesting—competitive but could be dilutive if triggered; severance outside CoC at 1× base + average bonus with partial acceleration (post-2023 awards to 12 months) reduces cliff risk .
  • Governance quality: Separation of chair/CEO, independent committees, strong attendance, and a 2023 clawback policy point to robust oversight, mitigating dual-role concerns from CEO-director status .
  • Near-term trading signals: No option exercises in 2024; watch RSU vest dates (Mar 2026–Mar 2028) for potential supply; ESPP participation modest (3,500 shares purchased in 2024), indicating ongoing accumulation behavior rather than distribution .